Brooke Kaye Coombes

Brooke Kaye Coombes

Auto-generated profile, based on publicly available information

Brooke Kaye Coombes

Centre for Innovation in Pain and Health Research (CIPHeR), The University of Queensland, Brisbane, Australia; School of Health and Rehabilitation Sciences, The University of Queensland, 84A Services Rd, St Lucia, QLD, 4072, Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in The Lancet
Verified
Journal Article
Open access
BCBrooke K Coombes
Brooke K Coombes
LBLeanne Bisset
Leanne Bisset
BVBill Vicenzino
Bill Vicenzino
Few evidence-based treatment guidelines for tendinopathy exist. We undertook a systematic review of randomised trials to establish clinical efficacy and risk of adverse events for treatment by injection. We searched eight databases without language, publication, or date restrictions. We included randomised trials assessing efficacy of one or more peritendinous injections with placebo or non-surgical interventions for tendinopathy, scoring more than 50% on the modified physiotherapy evidence database scale. We undertook meta-analyses with a random-effects model, and estimated relative risk and standardised mean differences (SMDs). The primary outcome of clinical efficacy was protocol-defined pain score in the short term (4 weeks, range 0-12), intermediate term (26 weeks, 13-26), or long term (52 weeks, ≥52). Adverse events were also reported. 3824 trials were identified and 41 met inclusion criteria, providing data for 2672 participants. We showed consistent findings between many high-quality randomised controlled trials that corticosteroid injections reduced pain in the short term compared with other interventions, but this effect was reversed at intermediate and long terms. For example, in pooled analysis of treatment for lateral epicondylalgia, corticosteroid injection had a large effect (defined as SMD>0·8) on reduction of pain compared with no intervention in the short term (SMD 1·44, 95% CI 1·17-1·71, p<0·0001), but no intervention was favoured at intermediate term (-0·40, -0·67 to -0·14, p<0·003) and long term (-0·31, -0·61 to -0·01, p=0·05). Short-term efficacy of corticosteroid injections for rotator-cuff tendinopathy is not clear. Of 991 participants who received corticosteroid injections in studies that reported adverse events, only one (0·1%) had a serious adverse event (tendon rupture). By comparison with placebo, reductions in pain were reported after injections of sodium hyaluronate (short [3·91, 3·54-4·28, p<0·0001], intermediate [2·89, 2·58-3·20, p<0·0001], and long [3·91, 3·55-4·28, p<0·0001] terms), botulinum toxin (short term [1·23, 0·67-1·78, p<0·0001]), and prolotherapy (intermediate term [2·62, 1·36-3·88, p<0·0001]) for treatment of lateral epicondylalgia. Lauromacrogol (polidocanol), aprotinin, and platelet-rich plasma were not more efficacious than was placebo for Achilles tendinopathy, while prolotherapy was not more effective than was eccentric exercise. Despite the effectiveness of corticosteroid injections in the short term, non-corticosteroid injections might be of benefit for long-term treatment of lateral epicondylalgia. However, response to injection should not be generalised because of variation in effect between sites of tendinopathy. None.

6 February 2013 in JAMA
Verified
Journal Article
Open access
PDF file
BCBrooke K. Coombes
Brooke K. Coombes
LBLeanne Bisset
Leanne Bisset
PBPeter Brooks
Peter Brooks
Asaduzzaman KhanAsaduzzaman Khan
Asaduzzaman Khan
BVBill Vicenzino
Bill Vicenzino
Use of corticosteroid injections to treat lateral epicondylalgia is increasingly discouraged,1,2 partly because evidence of long-term efficacy has not been found,3-5 and due to high recurrence rates.3,6 In a randomized controlled trial with 1-year follow-up,3 recurrence was evident in 72% of patients receiving corticosteroid injection compared with 8% after physiotherapy.

1 November 2015 in Journal of Orthopaedic & Sports Physical Therapy
Verified
Journal Article
Closed access
BCBrooke K. Coombes
Brooke K. Coombes
LBLeanne Bisset
Leanne Bisset
BVBill Vicenzino
Bill Vicenzino
Synopsis: Clear guidelines for the clinical management of individuals with lateral elbow tendinopathy (LET) are hampered by many proposed interventions and the condition's prognosis, ranging from immediate resolution of symptoms following simple advice in some patients to long-lasting problems, regardless of treatment, in others. This is compounded by our lack of understanding of the complexity of the underlying pathophysiology of LET. In this article, we collate evidence and expert opinion on the pathophysiology, clinical presentation, and differential diagnosis of LET. Factors that might provide prognostic value or direction for physical rehabilitation, such as the presence of neck pain, tendon tears, or central sensitization, are canvassed. Clinical recommendations for physical rehabilitation are provided, including the prescription of exercise and adjunctive physical therapy and pharmacotherapy. A preliminary algorithm, including targeted interventions, for the management of subgroups of patients with LET based on identified prognostic factors is proposed. Further research is needed to evaluate whether such an approach may lead to improved outcomes and more efficient resource allocation. J Orthop Sports Phys Ther 2015;45(11):938–949. Epub 17 Sep 2015. doi:10.2519/jospt.2015.5841

2 December 2008 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
BCB K Coombes
B K Coombes
LBLeanne Bisset
Leanne Bisset
BVB Vicenzino
B Vicenzino
Tennis elbow or lateral epicondylalgia is a diagnosis familiar to many within the general community and presents with an uncomplicated clinical picture in most cases. However, the underlying pathophysiology presents a more complex state and its management has not been conclusively determined. Research on this topic extends across anatomical, biomechanical and clinical literature; however, integration of findings is lacking. We propose that the current understanding of the underlying pathophysiology of lateral epicondylalgia can be conceptualised as encompassing three interrelated components: (i) the local tendon pathology, (ii) changes in the pain system, and (iii) motor system impairments. This paper presents a model that integrates these components on the basis of a literature review with the express aim of assisting in the targeting of specific treatments or combinations thereof to individual patients.

1 September 2012 in The Clinical Journal of Pain
Verified
Journal Article
Closed access
BCBrooke K. B.Phty Coombes
Brooke K. B.Phty Coombes
LBLeanne Bisset
Leanne Bisset
BVBill Vicenzino
Bill Vicenzino
Objectives: To evaluate if sensory, motor, and psychological factors are different in severe lateral epicondylalgia compared with less severe cases and control. Methods: A total of 164 patients with unilateral lateral epicondylalgia and 62 healthy control participants of comparable age and sex underwent the following testing: quantitative sensory testing (pressure, thermal pain thresholds), pain-free grip, quality of life (EuroQol), and psychological (Hospital Anxiety and Depression Scale, Tampa Scale for Kinesiophobia) testing. Cluster analysis classified patients into mild, moderate, or severe subgroups using the Patient Rated Tennis Elbow Evaluation. Data were then evaluated to determine differences between control and lateral epicondylalgia subgroups. Results: Bilateral cold hyperalgesia (affected elbow, standardized mean difference (SMD) −1.14, P=0.000; unaffected elbow SMD −0.94, P=0.000) and unilateral heat hyperalgesia (SMD −1.06, P=0.001) were evident in severe lateral epicondylalgia in comparison to healthy controls. All patient groups regardless of severity demonstrated bilateral and widespread mechanical hyperalgesia relative to controls (P0.8) at all sites. Quality of life was significantly poorer in patients with severe symptoms, whereas anxiety, depression, and kinesiophobia did not differ between subgroups. Discussion: Lateral epicondylalgia patients presenting with severe pain and disability could be distinguished by hypersensitivity to thermal stimuli, notably bilateral cold hyperalgesia. Findings may implicate a combination of central, peripheral, and sympathetic nervous system processes and may help explain the poorer outcomes found in this subpopulation.

3 October 2017 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
BCB. K. Coombes
B. K. Coombes
KTK. Tucker
K. Tucker
BVB. Vicenzino
B. Vicenzino
VVV. Vuvan
V. Vuvan
RMRebecca Mellor
Rebecca Mellor
FHF. Hug
F. Hug